{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:42:09Z","timestamp":1759542129088,"version":"3.44.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,16]]},"DOI":"10.7759\/cureus.90257","type":"journal-article","created":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T02:39:01Z","timestamp":1755398341000},"source":"Crossref","is-referenced-by-count":1,"title":["Myofibroblastic Proliferation as a Secondary Malignancy From Radioactive Iodine Treatment for Thyroid Carcinoma: A Case Report"],"prefix":"10.7759","author":[{"given":"Adeel","family":"Riaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malay","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Arif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abu","family":"Hurrairah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varisha A","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01841","article-title":"Association between radioactive iodine treatment for pediatric and young adulthood differentiated thyroid cancer and risk of second primary malignancies","volume":"40","author":"Pasqual E","year":"2022","unstructured":"Pasqual E, Schonfeld S, Morton LM, Villoing D, Lee C, Berrington de Gonzalez A, Kitahara CM. Association between radioactive iodine treatment for pediatric and young adulthood differentiated thyroid cancer and risk of second primary malignancies. J Clin Oncol. 2022, 40:1439-49. 10.1200\/JCO.21.01841","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.0232","article-title":"Risk of hematologic malignancies after radioiodine treatment of well-differentiated thyroid cancer","volume":"36","author":"Molenaar RJ","year":"2018","unstructured":"Molenaar RJ, Sidana S, Radivoyevitch T, et al.. Risk of hematologic malignancies after radioiodine treatment of well-differentiated thyroid cancer. J Clin Oncol. 2018, 36:1831-9. 10.1200\/JCO.2017.75.0232","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2012.0307","article-title":"The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering Cancer Center risk group stratification","volume":"23","author":"Nixon IJ","year":"2013","unstructured":"Nixon IJ, Ganly I, Patel SG, et al.. The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering Cancer Center risk group stratification. Thyroid. 2013, 23:683-94. 10.1089\/thy.2012.0307","journal-title":"Thyroid"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3548-5","article-title":"Radioiodine - the success story of nuclear medicine : 75th anniversary of the first use of iodine-131 in humans","volume":"44","author":"McCready VR","year":"2017","unstructured":"McCready VR. Radioiodine - the success story of nuclear medicine : 75th anniversary of the first use of iodine-131 in humans. Eur J Nucl Med Mol Imaging. 2017, 44:179-82. 10.1007\/s00259-016-3548-5","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3109\/00016925109136645","article-title":"Some varied applications of radioactive isotopes to the localization and treatment of tumors","volume":"35","author":"Smithers DW","year":"1951","unstructured":"Smithers DW. Some varied applications of radioactive isotopes to the localization and treatment of tumors. Acta Radiol (Stockh). 1951, 35:49-61. 10.3109\/00016925109136645","journal-title":"Acta Radiol (Stockh)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1154","article-title":"The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer","volume":"93","author":"Brown AP","year":"2008","unstructured":"Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab. 2008, 93:504-15. 10.1210\/jc.2007-1154","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/0973-029X.119754","article-title":"Malignant inflammatory myofibroblastic tumor of the maxillary sinus","volume":"17","author":"Salehinejad J","year":"2013","unstructured":"Salehinejad J, Pazouki M, Gerayeli MA. Malignant inflammatory myofibroblastic tumor of the maxillary sinus. J Oral Maxillofac Pathol. 2013, 17:306-10. 10.4103\/0973-029X.119754","journal-title":"J Oral Maxillofac Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153662","article-title":"Inflammatory myofibroblastic tumour: state of the art","volume":"14","author":"Gros L","year":"2022","unstructured":"Gros L, Dei Tos AP, Jones RL, Digklia A. Inflammatory myofibroblastic tumour: state of the art. Cancers (Basel). 2022, 14:10.3390\/cancers14153662","journal-title":"Cancers (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/379349-myofibroblastic-proliferation-as-a-secondary-malignancy-from-radioactive-iodine-treatment-for-thyroid-carcinoma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T02:39:04Z","timestamp":1755398344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/379349-myofibroblastic-proliferation-as-a-secondary-malignancy-from-radioactive-iodine-treatment-for-thyroid-carcinoma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,16]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.90257","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,16]]}}}